Maybe I missed it, but other than speculation as to what Zenith should be worth in light of the Celgene deal, i didn't see the usual discussion of similarities, differences, and potential impacts on the clinical value of Zen 3694 if any. Can someone point me to that discussion, if it took place? And if not, would anyone care to speculate on possible clinical implications/problematic competition or not and why?